| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 8.116 | EUR 0 | |
| DIA.MI - DiaSorin SpA | SELL | -880 @ EUR 93.26 | EUR -82,069 | The ETF sold 880 shares of DIA.MI on 2025-04-04. The shares were previously bought for an average price of EUR 99.7953. The DiaSorin SpA shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of EUR 5,751 (USD $6,351) |
| AMP.MI - Amplifon SpA | SELL | -4,796 @ EUR 18.51 | EUR -88,774 | The ETF sold 4796 shares of AMP.MI on 2025-04-04. The shares were previously bought for an average price of EUR 23.7778. The Amplifon SpA shares were sold for -22.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 25,264 (USD $27,901) |
| DEMANT.CO - | SELL | -3,432 @ DKK 29.0598 | DKK -99,733 | The ETF sold 3432 shares of DEMANT.CO on 2025-04-04. The shares were previously bought for an average price of DKK 34.8311. The shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of DKK 19,807 (USD $2,932) |
| ZEAL.CO - | SELL | -2,464 @ DKK 57.1277 | DKK -140,763 | The ETF sold 2464 shares of ZEAL.CO on 2025-04-04. The shares were previously bought for an average price of DKK 84.43. The shares were sold for -32.3% lower than average price of previous purchases. This resulted in an overall loss of DKK 67,273 (USD $9,957) |
| HIK.L - | SELL | -6,380 @ GBP 22.1026 | GBP -141,015 | The ETF sold 6380 shares of HIK.L on 2025-04-04. The shares were previously bought for an average price of GBP 24.7096. The shares were sold for -10.6% lower than average price of previous purchases. This resulted in an overall loss of GBP 16,633 (USD $21,770) |
| IPN.PA - Ipsen SA | SELL | -1,452 @ EUR 102.9 | EUR -149,411 | The ETF sold 1452 shares of IPN.PA on 2025-04-04. The shares were previously bought for an average price of EUR 110.194. The Ipsen SA shares were sold for -6.6% lower than average price of previous purchases. This resulted in an overall loss of EUR 10,591 (USD $11,696) |
| DIM.PA - Sartorius Stedim Biotech | SELL | -1,100 @ EUR 164.5 | EUR -180,950 | The ETF sold 1100 shares of DIM.PA on 2025-04-04. The shares were previously bought for an average price of EUR 188.505. The Sartorius Stedim Biotech shares were sold for -12.7% lower than average price of previous purchases. This resulted in an overall loss of EUR 26,406 (USD $29,162) |
| BIM.PA - BioMerieux | SELL | -1,584 @ EUR 114.7 | EUR -181,685 | The ETF sold 1584 shares of BIM.PA on 2025-04-04. The shares were previously bought for an average price of EUR 108.075. The BioMerieux shares were sold for 6.1% higher than average price of previous purchases. This sale made a profit of EUR 10,494 (USD $11,588) |
| SOBI.ST - | SELL | -7,524 @ SEK 24.8734 | SEK -187,147 | The ETF sold 7524 shares of SOBI.ST on 2025-04-04. The shares were previously bought for an average price of SEK 27.1865. The shares were sold for -8.5% lower than average price of previous purchases. This resulted in an overall loss of SEK 17,404 (USD $1,778) |
| SRT3.DE - Sartorius AG | SELL | -1,012 @ EUR 187.95 | EUR -190,205 | The ETF sold 1012 shares of SRT3.DE on 2025-04-04. The shares were previously bought for an average price of EUR 223.995. The Sartorius AG shares were sold for -16.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 36,478 (USD $40,285) |
| ORNBV.HE - Orion Oyj | SELL | -4,136 @ EUR 52.56 | EUR -217,388 | The ETF sold 4136 shares of ORNBV.HE on 2025-04-04. The shares were previously bought for an average price of EUR 47.9221. The Orion Oyj shares were sold for 9.7% higher than average price of previous purchases. This sale made a profit of EUR 19,182 (USD $21,185) |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | SELL | -4,400 @ EUR 50.65 | EUR -222,860 | The ETF sold 4400 shares of REC.MI on 2025-04-04. The shares were previously bought for an average price of EUR 52.8916. The Recordati Industria Chimica e Farmaceutica SpA shares were sold for -4.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 9,863 (USD $10,893) |
| ERF.PA - Eurofins Scientific SE | SELL | -5,148 @ EUR 47.75 | EUR -245,817 | The ETF sold 5148 shares of ERF.PA on 2025-04-04. The shares were previously bought for an average price of EUR 49.0189. The Eurofins Scientific SE shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of EUR 6,532 (USD $7,214) |
| QIA.DE - QIAGEN NV | SELL | -8,228 @ EUR 35.33 | EUR -290,695 | The ETF sold 8228 shares of QIA.DE on 2025-04-04. The shares were previously bought for an average price of EUR 36.5768. The QIAGEN NV shares were sold for -3.4% lower than average price of previous purchases. This resulted in an overall loss of EUR 10,259 (USD $11,329) |
| GALD.SW - | SELL | -3,608 @ CHF 86.7638 | CHF -313,044 | The ETF sold 3608 shares of GALD.SW on 2025-04-04. The shares were previously bought for an average price of CHF 97.4302. The shares were sold for -10.9% lower than average price of previous purchases. This resulted in an overall loss of CHF 38,484 (USD $44,790) |
| FME.DE - Fresenius Medical Care AG | SELL | -7,876 @ EUR 44.5 | EUR -350,482 | The ETF sold 7876 shares of FME.DE on 2025-04-04. The shares were previously bought for an average price of EUR 44.5368. The Fresenius Medical Care AG shares were sold for -0.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 290 (USD $320) |
| RO.SW - | SELL | -1,232 @ CHF 295.235 | CHF -363,730 | The ETF sold 1232 shares of RO.SW on 2025-04-04. The shares were previously bought for an average price of CHF 306.98. The shares were sold for -3.8% lower than average price of previous purchases. This resulted in an overall loss of CHF 14,470 (USD $16,841) |
| SN.L - Smith & Nephew PLC | SELL | -31,680 @ GBP 12.1346 | GBP -384,424 | The ETF sold 31680 shares of SN.L on 2025-04-04. The shares were previously bought for an average price of GBP 13.1828. The Smith & Nephew PLC shares were sold for -8.0% lower than average price of previous purchases. This resulted in an overall loss of GBP 33,207 (USD $43,460) |
| GMAB.CO - | SELL | -2,376 @ DKK 167.751 | DKK -398,576 | The ETF sold 2376 shares of GMAB.CO on 2025-04-04. The shares were previously bought for an average price of DKK 197.126. The shares were sold for -14.9% lower than average price of previous purchases. This resulted in an overall loss of DKK 69,795 (USD $10,330) |
| STMN.SW - | SELL | -4,268 @ CHF 99.8783 | CHF -426,281 | The ETF sold 4268 shares of STMN.SW on 2025-04-04. The shares were previously bought for an average price of CHF 121.688. The shares were sold for -17.9% lower than average price of previous purchases. This resulted in an overall loss of CHF 93,084 (USD $108,337) |
| COLO-B.CO - | SELL | -4,796 @ DKK 92.9431 | DKK -445,755 | The ETF sold 4796 shares of COLO-B.CO on 2025-04-04. The shares were previously bought for an average price of DKK 100.135. The shares were sold for -7.2% lower than average price of previous purchases. This resulted in an overall loss of DKK 34,492 (USD $5,105) |
| SHL.DE - Siemens Healthineers AG | SELL | -10,692 @ EUR 44.57 | EUR -476,542 | The ETF sold 10692 shares of SHL.DE on 2025-04-04. The shares were previously bought for an average price of EUR 51.7393. The Siemens Healthineers AG shares were sold for -13.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 76,654 (USD $84,655) |
| SOON.SW - | SELL | -1,936 @ CHF 251.449 | CHF -486,805 | The ETF sold 1936 shares of SOON.SW on 2025-04-04. The shares were previously bought for an average price of CHF 303.998. The shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of CHF 101,735 (USD $118,404) |
| SDZ.SW - | SELL | -15,884 @ CHF 35.0711 | CHF -557,069 | The ETF sold 15884 shares of SDZ.SW on 2025-04-04. The shares were previously bought for an average price of CHF 39.9728. The shares were sold for -12.3% lower than average price of previous purchases. This resulted in an overall loss of CHF 77,859 (USD $90,617) |
| MRK.DE - Merck KGaA | SELL | -4,928 @ EUR 117.75 | EUR -580,272 | The ETF sold 4928 shares of MRK.DE on 2025-04-04. The shares were previously bought for an average price of EUR 137.277. The Merck KGaA shares were sold for -14.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 96,229 (USD $106,275) |
| FRE.DE - Fresenius SE & Co KGaA | SELL | -16,060 @ EUR 38.06 | EUR -611,244 | The ETF sold 16060 shares of FRE.DE on 2025-04-04. The shares were previously bought for an average price of EUR 35.6746. The Fresenius SE & Co KGaA shares were sold for 6.7% higher than average price of previous purchases. This sale made a profit of EUR 38,310 (USD $42,308) |
| PHIA.AS - Koninklijke Philips NV | SELL | -30,404 @ EUR 20.77 | EUR -631,491 | The ETF sold 30404 shares of PHIA.AS on 2025-04-04. The shares were previously bought for an average price of EUR 24.4258. The Koninklijke Philips NV shares were sold for -15.0% lower than average price of previous purchases. This resulted in an overall loss of EUR 111,151 (USD $122,753) |
| UCB.BR - UCB SA | SELL | -4,796 @ EUR 150.65 | EUR -722,517 | The ETF sold 4796 shares of UCB.BR on 2025-04-04. The shares were previously bought for an average price of EUR 181.816. The UCB SA shares were sold for -17.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 149,472 (USD $165,071) |
| BAYN.DE - Bayer AG | SELL | -37,356 @ EUR 20.095 | EUR -750,669 | The ETF sold 37356 shares of BAYN.DE on 2025-04-04. The shares were previously bought for an average price of EUR 21.0786. The Bayer AG shares were sold for -4.7% lower than average price of previous purchases. This resulted in an overall loss of EUR 36,743 (USD $40,579) |
| ARGX.BR - Argenx SE | SELL | -2,288 @ EUR 520.4 | EUR -1,190,675 | The ETF sold 2288 shares of ARGX.BR on 2025-04-04. The shares were previously bought for an average price of EUR 578.845. The Argenx SE shares were sold for -10.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 133,722 (USD $147,679) |
| ALC.SW - | SELL | -19,008 @ CHF 77.3903 | CHF -1,471,035 | The ETF sold 19008 shares of ALC.SW on 2025-04-04. The shares were previously bought for an average price of CHF 82.9595. The shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of CHF 105,859 (USD $123,206) |
| LONN.SW - | SELL | -2,728 @ CHF 543.283 | CHF -1,482,076 | The ETF sold 2728 shares of LONN.SW on 2025-04-04. The shares were previously bought for an average price of CHF 575.065. The shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of CHF 86,701 (USD $100,906) |
| HLN.L - Haleon PLC | SELL | -344,388 @ GBP 4.5159 | GBP -1,555,222 | The ETF sold 344388 shares of HLN.L on 2025-04-04. The shares were previously bought for an average price of GBP 4.70251. The Haleon PLC shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of GBP 64,266 (USD $84,116) |
| GSK.L - GlaxoSmithKline PLC | SELL | -157,696 @ GBP 16.6918 | GBP -2,632,230 | The ETF sold 157696 shares of GSK.L on 2025-04-04. The shares were previously bought for an average price of GBP 16.8573. The GlaxoSmithKline PLC shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of GBP 26,099 (USD $34,163) |
| EL.PA - EssilorLuxottica SA | SELL | -11,308 @ EUR 243.4 | EUR -2,752,367 | The ETF sold 11308 shares of EL.PA on 2025-04-04. The shares were previously bought for an average price of EUR 250.052. The EssilorLuxottica SA shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of EUR 75,221 (USD $83,071) |
| SAN.PA - Sanofi SA | SELL | -43,252 @ EUR 96 | EUR -4,152,192 | The ETF sold 43252 shares of SAN.PA on 2025-04-04. The shares were previously bought for an average price of EUR 98.2822. The Sanofi SA shares were sold for -2.3% lower than average price of previous purchases. This resulted in an overall loss of EUR 98,710 (USD $109,013) |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -122,496 @ DKK 57.9051 | DKK -7,093,143 | The ETF sold 122496 shares of NOVO-B.CO on 2025-04-04. The shares were previously bought for an average price of DKK 74.4034. The Novo Nordisk A/S shares were sold for -22.2% lower than average price of previous purchases. This resulted in an overall loss of DKK 2,020,976 (USD $299,117) |
| NOVN.SW - | SELL | -74,976 @ CHF 97.8059 | CHF -7,333,095 | The ETF sold 74976 shares of NOVN.SW on 2025-04-04. The shares were previously bought for an average price of CHF 98.0225. The shares were sold for -0.2% lower than average price of previous purchases. This resulted in an overall loss of CHF 16,240 (USD $18,900) |
| ROG.SW - | SELL | -26,708 @ CHF 278.231 | CHF -7,430,994 | The ETF sold 26708 shares of ROG.SW on 2025-04-04. The shares were previously bought for an average price of CHF 290.255. The shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of CHF 321,137 (USD $373,763) |
| AZN.L - AstraZeneca PLC | SELL | -58,960 @ GBP 127.27 | GBP -7,503,839 | The ETF sold 58960 shares of AZN.L on 2025-04-04. The shares were previously bought for an average price of GBP 131.465. The AstraZeneca PLC shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of GBP 247,337 (USD $323,741) |